Standard Lithium Ltd.: Canaccord Genuity cuts target price to C$7 from C$9
SLI•Canaccord Genuity cut its target price for Standard Lithium Ltd. to C$7 from C$9.
Related News

Leerink Partners raises Lexeo Therapeutics target price to $23 from $15
LXEO•

Helus Pharma: Canaccord Genuity raises target price to $58 from $42
HELP•

Citi names Barrenjoey founding partner as new head of Australia and New Zealand equity capital markets
C•

Quirón study finds AI responses on kidney cancer guidelines win 92%-96% expert agreement
FSNUY•

ADMA Biologics CEO Adam S. Grossman reports sale of $288,120 in common shares
ADMA•